UNIVERSITY HEALTH NETWORK
TORONTO
Total Received
$46.6M
Total Awards
20
Last Updated
Mar 5, 2026
Yearly Funding Trend
$31.5M24
$10.5M25
$4.5M26
Top 20 Awards to UNIVERSITY HEALTH NETWORK
Largest individual federal awards on record for this recipient, ranked by obligated amount. Data through March 5, 2026.
| Award | Awarding Agency | Program | Place | FY | Obligation |
|---|---|---|---|---|---|
ASST_NON_UM1CA186644_075 NORTH AMERICAN STAR CONSORTIUM - THIS UM1 RENEWAL APPLICATION IS DESIGNATED THE NORTH AMERICAN STAR CONSORTIUM (NASC), WHICH INCLUDES MOFFITT CANCER CENTER (MCC) AS THE LEAD ACAD… | Department of Health and Human Services National Institutes of Health | 93.395 CANCER TREATMENT RESEARCH | — | 2024 | $14,859,350 |
ASST_NON_U01DK082874_075 OBSERVATION STUDY OF PERSONS WITH CHRONIC HEPATITIS B VIRUS INFECTION IN NORTH AMERICA - PROJECT SUMMARY BACKGROUND THE HEPATITIS B RESEARCH NETWORK (HBRN) WAS CREATED IN 2008 TO… | Department of Health and Human Services National Institutes of Health | 93.847 DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH | — | 2025 | $6,658,142 |
ASST_NON_R01AI085043_075 MECHANISMS OF VIRAL PERSISTENCE - PROJECT SUMMARY/ABSTRACT CHRONIC VIRAL INFECTIONS AND THE CO-INFECTIONS THEY FOSTER ARE AMONG THE GREATEST HEALTH CONCERNS WORLDWIDE. ALTHOUGH TH… | Department of Health and Human Services National Institutes of Health | 93.855 ALLERGY AND INFECTIOUS DISEASES RESEARCH | — | 2026 | $4,535,978 |
ASST_NON_R01AG077481_075 ESTABLISHING REFERENCE VALUES AND CLINICAL DECISION POINTS FOR QUANTITATIVE VIDEOFLUOROSCOPIC MEASURES OF SWALLOWING - PROJECT SUMMARY/ABSTRACT DYSPHAGIA (SWALLOWING IMPAIRMENT) I… | Department of Health and Human Services National Institutes of Health | 93.866 AGING RESEARCH | — | 2024 | $3,572,615 |
ASST_NON_R01DC011020_075 PHYSIOLOGICAL FLOW OF LIQUIDS USED IN DYSPHAGIA MANAGEMENT (PREVIOUSLY TONGUE-PRESSURE TIMING FOR LIQUID FLOW DETECTION AND CONTROL IN SWALLOWING) - DESCRIPTION (PROVIDED BY… | Department of Health and Human Services National Institutes of Health | 93.173 RESEARCH RELATED TO DEAFNESS AND COMMUNICATION DISORDERS | — | 2025 | $2,836,460 |
ASST_NON_R01CA255670_075 MECHANISTIC INVESTIGATIONS OF MICROBIOME-DRIVEN ARYL HYDROCARBON RECEPTOR ACTIVITY AND MACROPHAGE FUNCTION IN PANCREATIC CANCER. - PANCREATIC DUCTAL ADENOCARCINOMA (PDAC) IS ONE O… | Department of Health and Human Services National Institutes of Health | 93.395 CANCER TREATMENT RESEARCH | — | 2024 | $1,832,774 |
ASST_NON_R01AI173319_075 IMMUNOENGINEERING OF DONOR LUNGS TO OPTIMIZE LONG-TERM GRAFT FUNCTION - PROJECT SUMMARY LUNG TRANSPLANTATION IS THE ONLY TREATMENT OPTION FOR PATIENTS WITH END-STAGE LUNG DISEASE.… | Department of Health and Human Services National Institutes of Health | 93.855 ALLERGY AND INFECTIOUS DISEASES RESEARCH | — | 2024 | $1,793,519 |
ASST_NON_U01HL163298_075 CATCH: CREATING ACCESS TO TRANSPLANT FOR CANDIDATES WHO ARE HIGH RISK - PROJECT SUMMARY TODAY, LUNG TRANSPLANTATION FOR PATIENTS WITH END-STAGE LUNG DISEASE HAS BECOME INCREASINGL… | Department of Health and Human Services National Institutes of Health | 93.837 CARDIOVASCULAR DISEASES RESEARCH | — | 2024 | $1,592,826 |
ASST_NON_R01CA263196_075 ESTABLISHING THE CLINICAL UTILITY OF CELL-FREE TUMOR DNA METHYLATION PROFILING AS A RELIABLE LIQUID BIOPSY APPROACH IN BRAIN TUMORS - PROJECT SUMMARY TUMORS OF THE CENTRAL NERVOUS… | Department of Health and Human Services National Institutes of Health | 93.394 CANCER DETECTION AND DIAGNOSIS RESEARCH | — | 2024 | $1,572,445 |
ASST_NON_R01HD104553_075 DEFINING THE IMPACT OF DOLUTEGRAVIR ON THE MATERNAL METABOLIC ENVIRONMENT AND ITS IMPLICATIONS ON RISK OF CONGENITAL ANOMALIES. - PROJECT SUMMARY/ABSTRACT: DOLUTEGRAVIR (DTG)-BASE… | Department of Health and Human Services National Institutes of Health | 93.865 CHILD HEALTH AND HUMAN DEVELOPMENT EXTRAMURAL RESEARCH | — | 2024 | $1,443,222 |
ASST_NON_U01CA253383_075 UNDERSTANDING THE MOLECULAR MECHANISM OF A PROTEIN-RECYCLING COMPLEX IN SMALL CELL LUNG CANCER TREATMENT RESISTANCE. - PROJECT SUMMARY SMALL CELL LUNG CANCER (SCLC) PATIENTS HAVE… | Department of Health and Human Services National Institutes of Health | 93.393 CANCER CAUSE AND PREVENTION RESEARCH | — | 2024 | $1,433,057 |
ASST_NON_W81XWH2110367_097 INHIBITING INTERACTION OF PNUTS WITH THE MYC FAMILY OF ONCOPROTEINS TO EFFECTIVELY TARGET BREAST CANCER | Department of Defense Defense Health Agency | 12.420 MILITARY MEDICAL RESEARCH AND DEVELOPMENT | — | 2024 | $1,232,483 |
ASST_NON_W81XWH1910779_097 GENOMIC AND EPIGENOMIC CHARACTERIZATION OF NF1-RELATED SPECTRUM OF PERIPHERAL NERVE SHEATH TUMORS DE-OBLIGATE FUNDS TO CLOSE AWARD 1. PER SECTION 711 OF THE NATIONAL DEFENSE AUTHO… | Department of Defense Defense Health Agency | 12.420 MILITARY MEDICAL RESEARCH AND DEVELOPMENT | — | 2024 | $824,141 |
ASST_NON_W81XWH2210750_097 INVESTIGATION OF CELL TYPES RESPONSIBLE FOR SEIZURE GENERATION IN A MODEL OF NEUROFIBROMATOSIS TYPE 1 EXTEND THE PERIOD OF PERFORMANCE INVESTIGATION OF CELL TYPES RESPONSIBLE FOR… | Department of Defense Defense Health Agency | 12.420 MILITARY MEDICAL RESEARCH AND DEVELOPMENT | — | 2025 | $699,503 |
ASST_NON_W81XWH1910177_097 USING ADMINISTRATIVE HEALTH DATA TO IDENTIFY PATIENTS WITH NF1 IN ONTARIO, CANADA, AND TO ASSESS PREVALENCE, MORTALITY, AND HEALTH CARE UTILIZATION PATTERNS EXTEND THE PERIOD OF P… | Department of Defense Defense Health Agency | 12.420 MILITARY MEDICAL RESEARCH AND DEVELOPMENT | — | 2024 | $576,273 |
ASST_NON_HT94252410483_097 LINEAGE TRACING IN MALIGNANT PERIPHERAL NERVE SHEATH TUMORS AND PLEXIFORM NEUROFIBROMAS TO ASSESS TUMORAL HETEROGENEITY AND MECHANISMS OF DRUG RESISTANCE | Department of Defense Defense Health Agency | 12.420 MILITARY MEDICAL RESEARCH AND DEVELOPMENT | — | 2024 | $303,156 |
CONT_AWD_75N91021P00136_7529_-NONE-_-NONE- THE CONTRACTOR SHALL RETRIEVE EXISTING DATA FROM MEDICAL RECORDS FOR PEDIATRIC CANCER PATIENTS TREATED AT THEIR INSTITUTION WITH PHOTON THERAPY. DE-IDENTIFIED CLINICAL AND TREATME… | Department of Health and Human Services National Institutes of Health | — | — | 2024 | $293,970 |
ASST_NON_HT94252510938_097 IDENTIFICATION OF MOLECULAR BIOMARKERS FOR INVASIVE GLIOBLASTOMA CELL STATES AND TUMOR MICROENVIRONMENT MODULATION | Department of Defense Defense Health Agency | 12.420 MILITARY MEDICAL RESEARCH AND DEVELOPMENT | — | 2025 | $213,501 |
ASST_NON_R03HD104206_075 A LONGITUDINAL POPULATION-BASED BIRTH COHORT STUDY TO UNDERSTAND THE PAST, PRESENT, AND FUTURE OF CHILDREN AND YOUTH WITH TRAUMATIC BRAIN INJURY - PROJECT SUMMARY/ABSTRACT TRAUMAT… | Department of Health and Human Services National Institutes of Health | 93.865 CHILD HEALTH AND HUMAN DEVELOPMENT EXTRAMURAL RESEARCH | — | 2024 | $197,714 |
ASST_NON_R21CA296062_075 SEQUENTIAL INFECTION OF LABORATORY MICE FOR ENHANCED CANCER AND IMMUNOTHERAPY TRANSLATION - ABSTRACT MOUSE MODELS HAVE BEEN TREMENDOUSLY IMPORTANT TO UNDERSTAND AND DEVELOP TREATM… | Department of Health and Human Services National Institutes of Health | 93.394 CANCER DETECTION AND DIAGNOSIS RESEARCH | — | 2025 | $138,846 |
Top 20 awards shown, ranked by obligated amount. Dates reflect performance period; last-modified dates match USAspending.gov. Complete listings include all transaction history going back to FY2024.
Federal Programs (CFDA)
View All→12345678910
93.395 — CANCER TREATMENT RESEARCH$16.7M
93.847 — DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH$6.7M
93.855 — ALLERGY AND INFECTIOUS DISEASES RESEARCH$6.3M
12.420 — MILITARY MEDICAL RESEARCH AND DEVELOPMENT$3.8M
93.866 — AGING RESEARCH$3.6M
93.173 — RESEARCH RELATED TO DEAFNESS AND COMMUNICATION DISORDERS$2.8M
93.394 — CANCER DETECTION AND DIAGNOSIS RESEARCH$1.7M
93.865 — CHILD HEALTH AND HUMAN DEVELOPMENT EXTRAMURAL RESEARCH$1.6M
93.837 — CARDIOVASCULAR DISEASES RESEARCH$1.6M
93.393 — CANCER CAUSE AND PREVENTION RESEARCH$1.4M
Source: USAspending.gov · All Recipients